Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Targets and mechanisms for the regulation of translation in malignant transformation

Oncogene volume 23, pages 3180–3188 (2004)Cite this article

Abstract

There is increasing evidence that deregulation of gene expression at the level of mRNA translation can contribute to cell transformation and the malignant phenotype. Two steps in the pathway of polypeptide chain initiation, viz. the assembly of the 43S initiation complex catalysed by polypeptide chain initiation factor eIF2 and the binding of eIF4E to eIF4G during the recruitment of mRNA to the ribosome, have been shown to be likely targets for changes associated with tumorigenesis. The activity of eIF2 is controlled by changes in phosphorylation of the α subunit of this factor. The availability of eIF4E for binding to eIF4G is regulated by the phosphorylation of a small family of eIF4E-binding proteins (the 4E-BPs). The activities of the protein kinases and/or phosphatases responsible for the (de)phosphorylation of these substrates may in turn be controlled by cellular and viral oncogenes and tumour-suppressor genes. This review will describe recent aspects of the mechanisms involved, with particular emphasis on the regulation of the eIF2α kinase PKR and the control of 4E-BP phosphorylation by viral gene products, growth-inhibitory cytokines and the tumour-suppressor protein p53.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Abraham N, Jaramillo ML, Duncan PI, Méthot N, Icely PL, Stojdl DF, Barber GN and Bell JC . (1998). Exp. Cell Res., 244, 394–404.

  • Appella E . (2001). Eur. J. Biochem., 268, 2763.

  • Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z and Schwall RH . (1999). J. Clin. Invest, 104, 155–162.

  • Balachandran S, Kim CN, Yeh WC, Mak TW, Bhalla K and Barber GN . (1998). EMBO J., 17, 6888–6902.

  • Balachandran S, Roberts PC, Kipperman T, Bhalla KN, Compans RW, Archer DR and Barber GN . (2000). J. Virol., 74, 1513–1523.

  • Barber GN, Jagus R, Meurs EF, Hovanessian AG and Katze MG . (1995). J. Biol. Chem., 270, 17423–17428.

  • Baud V and Karin M . (2001). Trends Cell Biol., 11, 372–377.

  • Bauer C, Diesinger I, Brass N, Steinhart H, Iro H and Meese EU . (2001). Cancer, 92, 822–829.

  • Brass N, Heckel D, Sahin U, Pfreundschuh M, Sybrecht GW and Meese E . (1997). Hum. Mol. Genet., 6, 33–39.

  • Budihardjo I, Oliver H, Lutter M, Luo X and Wang XD . (1999). Annu. Rev. Cell Dev. Biol., 15, 269–290.

  • Caelles C, Helmberg A and Karin M . (1994). Nature, 370, 220–223.

  • Carter PS, Jarquin-Pardo M and De Benedetti A . (1999). Oncogene, 18, 4326–4335.

  • Chacko MS and Adamo ML . (2002). Endocrinology, 143, 525–534.

  • Chung J, Bachelder RE, Lipscomb EA, Shaw LM and Mercurio AM . (2002). J. Cell Biol., 158, 165–174.

  • Clemens M . (1992). Nature, 360, 210–211.

  • Clemens MJ . (2001). Signaling Pathways for Translation. Progress in Molecular and Subcellular Biology, Vol. 27. Rhoads RE (ed). Springer: Berlin, pp. 57–89.

    Book  Google Scholar 

  • Clemens MJ and Bommer UA . (1999). Int. J. Biochem. Cell Biol., 31, 1–23.

  • Clemens MJ, Bushell M, Jeffrey IW, Pain VM and Morley SJ . (2000). Cell Death Differ., 7, 603–615.

  • Clemens MJ and Elia A . (1997). J. Interferon Cytokine Res., 17, 503–524.

  • Constantinou C, Bushell M, Jeffrey IW, Tilleray V, West M, Frost V, Hensold J and Clemens MJ . (2003). Eur. J. Biochem., 270, 3122–3132.

  • Deb A, Zamanian-Daryoush M, Xu Z, Kadereit S and Williams BRG . (2001). EMBO J., 20, 2487–2496.

  • Der SD, Yang YL, Weissmann C and Williams BRG . (1997). Proc. Natl. Acad. Sci. USA, 94, 3279–3283.

  • Dilling MB, Germain GS, Dudkin L, Jayaraman AL, Zhang X, Harwood FC and Houghton PJ . (2002). J. Biol. Chem., 277, 13907–13917.

  • Donze O, Jagus R, Koromilas AE, Hershey JW and Sonenberg N . (1995). EMBO J., 14, 3828–3834.

  • Evan G and Littlewood T . (1998). Science, 281, 1317–1322.

  • Ewen ME and Miller SJ . (1996). Biochim. Biophys. Acta, 1242, 181–184.

  • Ewen ME, Oliver CJ, Sluss HK, Miller SJ and Peeper DS . (1995). Genes Dev., 9, 204–217.

  • Fox CJ, Hammerman PS, Cinalli RM, Master SR, Chodosh LA and Thompson CB . (2003). Genes Dev., 17, 1841–1854.

  • Fukuchi-Shimogori T, Ishii I, Kashiwagi K, Mashiba H, Ekimoto H and Igarashi K . (1997). Cancer Res., 57, 5041–5044.

  • Galy B, Creancier L, Prado-Lourenco L, Prats A-C and Prats H . (2001a). Oncogene, 20, 4613–4620.

  • Galy B, Créancier L, Zanibellato C, Prats AC and Prats H . (2001b). Oncogene, 20, 1669–1677.

  • Gao C and Tsuchida N . (1999). Jpn. J. Cancer Res., 90, 180–187.

  • Garcia MA, Guerra S, Gil J, Jimenez V and Esteban M . (2002). Oncogene, 21, 8379–8387.

  • Gil J and Esteban M . (2000). Oncogene, 19, 3665–3674.

  • Gingras AC, Gygi SP, Raught B, Polakiewicz RD, Abraham RT, Hoekstra MF, Aebersold R and Sonenberg N . (1999a). Genes Dev., 13, 1422–1437.

  • Gingras AC, Raught B, Gygi SP, Niedzwiecka A, Miron M, Burley SK, Polakiewicz RD, Wyslouch-Cieszynska A, Aebersold R and Sonenberg N . (2001a). Genes Dev., 15, 2852–2864.

  • Gingras AC, Raught B and Sonenberg N . (1999b). Annu. Rev. Biochem., 68, 913–963.

  • Gingras AC, Raught B and Sonenberg N . (2001b). Genes Dev., 15, 807–826.

  • Graff JR, De Benedetti A, Olson JW, Tamez P, Casero Jr RA and Zimmer SG . (1997). Biochem. Biophys. Res. Commun., 240, 15–20.

  • Graff JR and Zimmer SG . (2003). Clin. Exp. Metast., 20, 265–273.

  • Haines GK, Cajulis R, Hayden R, Duda R, Talamonti M and Radosevich JA . (1996). Tumour Biol., 17, 5–12.

  • Hidalgo M and Rowinsky EK . (2000). Oncogene, 19, 6680–6686.

  • Horton LE, Bushell M, Barth-Baus D, Tilleray VJ, Clemens MJ and Hensold J . (2002). Oncogene, 21, 5325–5334.

  • Jagus R, Joshi B and Barber GN . (1999). Int. J. Biochem. Cell Biol., 31, 123–138.

  • Jeffrey IW, Bushell M, Tilleray VJ, Morley S and Clemens MJ . (2002). Cancer Res., 62, 2272–2280.

  • Jiang H, Coleman J, Miskimins R and Miskimins WK . (2003). Cancer Cell Int., 3, 2.

  • Kim SH, Forman AP, Mathews MB and Gunnery S . (2000). Oncogene, 19, 3086–3094.

  • Kim SH, Gunnery S, Choe JK and Mathews MB . (2002). Oncogene, 21, 8741–8748.

  • Kiyosawa K, Tanaka E and Sodeyama T . (1998). Curr. Stud. Hematol. Blood Transfus., 62, 161–180.

  • Kokontis JM, Wagner AJ, O’Leary M, Liao S and Hay N . (2001). Oncogene, 20, 659–668.

  • Komano J, Maruo S, Kurozumi K, Oda T and Takada K . (1999). J. Virol., 73, 9827–9831.

  • Kozak M . (1991a). J. Cell Biol., 115, 887–903.

  • Kozak M . (1991b). J. Biol. Chem., 266, 19867–19870.

  • Laing KG, Elia A, Jeffrey I, Matys V, Tilleray VJ, Souberbielle B and Clemens MJ . (2002). Virology, 297, 253–269.

  • Li SN, Sonenberg N, Gingras AC, Peterson M, Avdulov S, Polunovsky VA and Bitterman PB . (2002). Mol. Cell. Biol., 22, 2853–2861.

  • Li S, Takasu T, Perlman DM, Peterson MS, Burrichter D, Avdulov S, Bitterman PB and Polunovsky VA . (2003). J. Biol. Chem., 278, 3015–3022.

  • Lobo MVT, Martín ME, Pérez MI, Alonso FJM, Redondo C, Alvarez MI and Salinas M . (2000). Histochem. J., 32, 139–150.

  • Marchenko ND, Zaika A and Moll UM . (2000). J. Biol. Chem., 275, 16202–16212.

  • Marth JD, Overell RW, Meier KE, Krebs EG and Perlmutter RM . (1988). Nature, 332, 171–173.

  • Meijer HA and Thomas AAM . (2002). Biochem. J., 367, 1–11.

  • Meurs EF, Galabru J, Barber GN, Katze MG and Hovanessian AG . (1993). Proc. Natl. Acad. Sci. USA, 90, 232–236.

  • Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P and Moll UM . (2003). Mol. Cell, 11, 577–590.

  • Miller SJ, Suthiphongchai T, Zambetti GP and Ewen ME . (2000). Mol. Cell. Biol., 20, 8420–8431.

  • Morley SJ, Jeffrey I, Bushell M, Pain VM and Clemens MJ . (2000). FEBS Lett., 477, 229–236.

  • Morley SJ, McKendrick L and Bushell M . (1998). FEBS Lett., 438, 41–48.

  • Mosner J, Mummenbrauer T, Bauer C, Sczakiel G, Grosse F and Deppert W . (1995). EMBO J., 14, 4442–4449.

  • Nanbo A, Inoue K, Adachi-Takasawa K and Takada K . (2002). EMBO J., 21, 954–965.

  • Nicholson KM and Anderson NG . (2002). Cell. Signal., 14, 381–395.

  • Nomura M, He Z, Koyama I, Ma WY, Miyamoto K and Dong Z . (2003). Mol. Carcinogen., 38, 25–32.

  • Nussbaum JM, Major M and Gunnery S . (2003). Cancer Lett., 196, 207–216.

  • Packham G, Porter CW and Cleveland JL . (1996). Oncogene, 13, 461–469.

  • Parker LM, Fierro-Monti I and Mathews MB . (2001). J. Biol. Chem., 276, 32522–32530.

  • Patel RC and Sen GC . (1998). EMBO J., 17, 4379–4390.

  • Polunovsky VA, Gingras AC, Sonenberg N, Peterson M, Tan A, Rubins JB, Manivel JC and Bitterman PB . (2000). J. Biol. Chem., 275, 24776–24780.

  • Polunovsky VA, Rosenwald IB, Tan AT, White J, Chiang L, Sonenberg N and Bitterman PB . (1996). Mol. Cell. Biol., 16, 6573–6581.

  • Prendergast GC . (1999). Oncogene, 18, 2967–2987.

  • Rau M, Ohlmann T, Morley SJ and Pain VM . (1996). J. Biol. Chem., 271, 8983–8990.

  • Raught B, Gingras AC and Sonenberg N . (2001). Proc. Natl. Acad. Sci. USA, 98, 7037–7044.

  • Raveh T, Hovanessian AG, Meurs EF, Sonenberg N and Kimchi A . (1996). J. Biol. Chem., 271, 25479–25484.

  • Rosenwald IB . (1996a). Bioessays, 18, 243–250.

  • Rosenwald IB . (1996b). Cancer Lett., 102, 113–123.

  • Rosenwald IB, Hutzler MJ, Wang ST, Savas L and Fraire AE . (2001). Cancer, 92, 2164–2171.

  • Rosenwald IB, Rhoads DB, Callanan LD, Isselbacher KJ and Schmidt EV . (1993). Proc. Natl. Acad. Sci. USA, 90, 6175–6178.

  • Ruf IK, Rhyne PW, Yang CY, Cleveland JL and Sample JT . (2000). J. Virol., 74, 10223–10228.

  • Ryan KM, Phillips AC and Vousden KH . (2001). Curr. Opin. Cell Biol., 13, 332–337.

  • Saelens X, Kalai M and Vandenabeele P . (2001). J. Biol. Chem., 276, 41620–41628.

  • Salaün P, Pyronnet S, Morales J, Mulner-Lorillon O, Bellé R, Sonenberg N and Cormier P . (2003). Dev. Biol., 255, 428–439.

  • Savinova O, Joshi B and Jagus R . (1999). Int. J. Biochem. Cell Biol., 31, 175–189.

  • Sharp TV, Schwemmle M, Jeffrey I, Laing K, Mellor H, Proud CG, Hilse K and Clemens MJ . (1993). Nucleic Acids Res., 21, 4483–4490.

  • Sonenberg N . (1994). Biochimie, 76, 839–846.

  • Srivastava SP, Kumar KU and Kaufman RJ . (1998). J. Biol. Chem., 273, 2416–2423.

  • Tan A, Bitterman P, Sonenberg N, Peterson M and Polunovsky V . (2000). Oncogene, 19, 1437–1447.

  • Taylor DR, Shi ST and Lai MMC . (2000). Microbe. Infect., 2, 1743–1756.

  • Tee AR and Proud CG . (2000). Oncogene, 19, 3021–3031.

  • Tokino T and Nakamura Y . (2000). Crit. Rev. Oncol. Hematol., 33, 1–6.

  • von der Haar T and McCarthy JE . (2002). Mol. Microbiol., 46, 531–544.

  • Vorburger SA, Pataer A, Yoshida K, Barber GN, Xia WY, Chiao P, Ellis LM, Hung MC, Swisher SG and Hunt KK . (2002). Oncogene, 21, 6278–6288.

  • Vousden KH . (2000). Cell, 103, 691–694.

  • Vyas J, Elia A and Clemens MJ . (2003). RNA, 9, 858–870.

  • Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC and Lynch DH . (1999). Nat. Med., 5, 157–163.

  • Wang S, Lloyd RV, Hutzler MJ, Rosenwald IB, Safran MS, Patwardhan NA and Khan A . (2001). Thyroid, 11, 1101–1107.

  • Wang ST, Rosenwald IB, Hutzler MJ, Pihan GA, Savas L, Chen JJ and Woda BA . (1999). Am. J. Pathol., 155, 247–255.

  • Williams BRG . (1999). Oncogene, 18, 6112–6120.

  • Yamamoto N, Takizawa T, Iwanaga Y and Shimizu N . (2000). FEBS Lett., 484, 153–158.

  • Young LS and Murray PG . (2003). Oncogene, 22, 5108–5121.

  • Zamanian-Daryoush M, Der SD and Williams BRG . (1999). Oncogene, 18, 315–326.

  • Zimmer SG, DeBenedetti A and Graff JR . (2000). Anticancer Res., 20, 1343–1351.

Download references

Acknowledgements

I am grateful to my colleagues Ian Jeffrey, Androulla Elia, Uli Bommer, Vivienne Tilleray, Constantina Constantinou and Jashmin Vyas for inspiring discussions and to Constantina Constantinou for assistance in preparation of the figures in this review. The work in my laboratory is funded by the Leukaemia Research Fund, the Cancer Prevention Research Trust and the Association for International Cancer Research.

Author information

Authors and Affiliations

  1. Translational Control Group, Biochemistry and Immunology, Department of Basic Medical Sciences, St George's Hospital Medical School, Cranmer Terrace, London, SW17 0RE, UK

    Michael J Clemens

Authors
  1. Michael J Clemens
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael J Clemens.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Clemens, M. Targets and mechanisms for the regulation of translation in malignant transformation. Oncogene 23, 3180–3188 (2004). https://doi.org/10.1038/sj.onc.1207544

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207544

Keywords

This article is cited by

Search

Advanced search

Quick links